The glucocorticoid hypothesis of depression: history and perspectives
https://doi.org/10.18699/VJ16.155
Abstract
An abnormality in adaptation to negative life events is considered as one of the main causes of the development of depressive symptoms. According to the corticosteroid receptor hypothesis of depression, stress-induced activation of the hypothalamicpituitary- adrenal (HPA) axis plays an important role in the induction of psycho-emotional disturbances. The end products of this axis, glucocorticoids, are involved in the formation of many physiological and behavioral responses to stress. Although the increase in hormone levels following a short-term intervention is directed towards rapid mobilization of the body’s efforts for overcoming potentially dangerous situation, a long-term exposure to stress or glucocorticoids may have negative consequences for mood or behavior. With respect to mechanisms of changing effects of glucocorticoids from protective to damaging, glucocorticoid receptors (GRs) received most attention. These receptors are widely expressed in the brain. They are important regulators of the transcriptional activities of numerous genes, including the gene for such a plasticity-related protein as the brain-derived neurotrophic factor (BDNF) which has been implicated in psychiatric disorders. In addition to direct effects on gene transcription, changes in expression of GR themselves resulting from stress and/or glucocorticoid effects, in turn can modify the functional responses to subsequent stimuli. The purpose of this review was to analyze available literature data on the effects of stress and glucocorticoids on the expression of GR in the hippocampus, which is traditionally considered as the most sensitive to stress brain structure. The review also addresses the implication of GR and BDNF interplay in the pathogenesis of stress-related disorders.
About the Authors
G. T. Shishkina
Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia
Russian Federation
Russian Federation
N. N. Dygalo
Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia
Novosibirsk State University, Novosibirsk, Russia
Russian Federation
Russian Federation
References
1. Alboni S., Tascedda F., Corsini D., Benatti C., Caggia F., Capone G., Barden N., Blom J.M., Brunello N. Stress induces altered CRE/ CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice. Neuropharmacology. 2011;60(7/8):1337-1346.
2. Arango-Lievano M., Lambert W.M., Bath K.G., Garabedian M.J., Chao M.V., Jeanneteau F. Neurotrophic-priming of glucocorticoid receptor signaling is essential for neuronal plasticity to stress and antidepressant treatment. Proc. Natl Acad. Sci. USA. 2015;112(51): 15737-15742.
3. Barbier E., Wang J.B. Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level. BMC Neurosci. 2009;10:132.
4. Boulle F., Velthuis H., Koedam K., Steinbusch H.W., van den Hove D.L., Kenis G., Gabriel C., Mocaer E., Franc B., Rognan D., Mongeau R., Lanfumey L. Behavioral and neurochemical characterization of TrkB-dependent mechanisms of agomelatine in glucocorticoid receptor-impaired mice. Eur. Neuropsychopharmacol. 2016; 26(1):65-77.
5. Boyle M.P., Brewer J.A., Funatsu M., Wozniak D.F., Tsien J.Z., Izumi Y., Muglia L.J. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc. Natl Acad. Sci. USA. 2005;102(2):473-478.
6. Brown E.S., Vera E., Frol A.B., Woolston D.J., Johnson B. Effects of chronic prednisone therapy on mood and memory. J. Affect. Disord. 2007;99(1-3):279-283.
7. Caudal D., Jay T.M., Godsil B.P. Behavioral stress induces regionallydistinct shifts of brain mineralocorticoid and glucocorticoid receptor levels. Front. Behav. Neurosci. 2014;8:19.
8. Chen J., Wang Z.Z., Zuo W., Zhang S., Chu S.F., Chen N.H. Effects of chronic mild stress on behavioral and neurobiological parameters – role of glucocorticoid. Horm. Behav. 2016;78:150-159.
9. Daskalakis N.P., De Kloet E.R., Yehuda R., Malaspina D., Kranz T.M. Early life stress effects on glucocorticoid-BDNF interplay in the hippocampus. Front. Mol. Neurosci. 2015;8:68.
10. Datson N.A., van den Oever J.M., Korobko O.B., Magarinos A.M., de Kloet E.R., McEwen B.S. Previous history of chronic stress changes the transcriptional response to glucocorticoid challenge in the dentate gyrus region of the male rat hippocampus. Endocrinology. 2013;154(9):3261-3272.
11. de Kloet E.R., Derijk R.H., Meijer O.C. Therapy Insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression? Nat. Clin. Pract. Endocrinol. Metab. 2007;3(2): 168-179.
12. de Kloet E.R., Oitzl M.S., Joëls M. Functional implications of brain corticosteroid receptor diversity. Cell Mol. Neurobiol. 1993;13(4): 433-455.
13. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiat. 2006;59(12):1116-1127.
14. Eraslan E., Akyazi İ., Ergül-Ekiz E., Matur E. Noise stress-induced changes in mRNA levels of corticotropin-releasing hormone family molecules and glucocorticoid receptors in the rat brain. Folia Biol. (Praha). 2015;61(2):66-73.
15. Finsterwald C., Alberini C.M. Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies. Neurobiol. Learn. Mem. 2014;112:17-29.
16. Fujikawa T., Soya H., Fukuoka H., Alam K.S., Yoshizato H., McEwen B.S., Nakashima K. A biphasic regulation of receptor mRNA expressions for growth hormone, glucocorticoid and mineralocorticoid in the rat dentate gyrus during acute stress. Brain. Res. 2000;874(2): 186-193.
17. Gibbons J.L. Cortisol secretion rate in depressive illness. Arch. Gen. Psychiat. 1964;10:572-575.
18. Gould E., Tanapat P. Stress and hippocampal neurogenesis. Biol. Psychiat. 1999;46(11):1472-1479.
19. Gray J.D., Milner T.A., McEwen B.S. Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors. Neuroscience. 2013;239:214-227.
20. Hansson A.C., Sommer W.H., Metsis M., Strömberg I., Agnati L.F., Fuxe K. Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by exon IV promoter. J. Neuroendocrinol. 2006;18(2):104-114.
21. Harris A.P., Holmes M.C., de Kloet E.R., Chapman K.E., Seckl J.R. Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour. Psychoneuroendocrinology. 2013;38(5): 648-658.
22. Herbert J. Cortisol and depression: three questions for psychiatry. Psychol. Med. 2013;43(3):449-469.
23. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000;23(5):477-501.
24. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitaryadrenocortical regulation. Endocr. Rev. 1996;17(2):187-205.
25. Jahn H., Schick M., Kiefer F., Kellner M., Yassouridis A., Wiedemann K. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch. Gen. Psychiat. 2004;61(12):1235-1244.
26. Jeanneteau F., Garabedian M.J., Chao M.V. Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect. Proc. Natl. Acad. Sci. USA. 2008;105(12):4862-4867.
27. Karandrea D., Kittas C., Kitraki E. Forced swimming differentially affects male and female brain corticosteroid receptors. Neuroendocrinology. 2002;75(4):217-226.
28. Kelly W.F., Checkley S.A., Bender D.A., Mashiter K. Cushing’s syndrome and depression – a prospective study of 26 patients. Br. J. Psychiat. 1983;142:16-19.
29. Kendler K.S., Karkowski L.M., Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiat. 1999;156(6):837-841.
30. Kim J.B., Ju J.Y., Kim J.H., Kim T.Y., Yang B.H., Lee Y.S., Son H. Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro. Brain Res. 2004;1027(1/2):1-10.
31. Kling M.A., Coleman V.H., Schulkin J. Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus? Depress Anxiety. 2009;26(7):641-649.
32. Lambert W.M., Xu C.F., Neubert T.A., Chao M.V., Garabedian M.J., Jeanneteau F.D. Brain-derived neurotrophic factor signaling rewrites the glucocorticoid transcriptome via glucocorticoid receptor phosphorylation. Mol. Cell Biol. 2013;33(18):3700-3714.
33. Larkin H., Shields J.J., Anda R.F. The health and social consequences of adverse childhood experiences (ACE) across the lifespan: an introduction to prevention and intervention in the community. J. Prev. Interv. Commun. 2012;40(4):263-270.
34. Lehmann M.L., Brachman R.A., Martinowich K., Schloesser R.J., Herkenham M. Glucocorticoids orchestrate divergent effects on mood through adult neurogenesis. J. Neurosci. 2013;33(7):2961-2972.
35. Mayer J.L., Klumpers L., Maslam S., de Kloet E.R., Joëls M., Lucassen P.J. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. J. Neuroendocrinol. 2006;18(8): 629-631.
36. Mizoguchi K., Ishige A., Aburada M., Tabira T. Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus. Neuroscience. 2003;119(3):887-897.
37. Mondelli V., Pariante C.M., Navari S., Aas M., D’Albenzio A., Di Forti M., Handley R., Hepgul N., Marques T.R., Taylor H., Papadopoulos A.S., Aitchison K.J., Murray R.M., Dazzan P. Higher cortisol levels are associated with smaller left hippocampal volume in firstepisode psychosis. Schizophr. Res. 2010;119(1-3):75-78.
38. Noguchi T., Makino S., Matsumoto R., Nakayama S., Nishiyama M., Terada Y., Hashimoto K. Regulation of glucocorticoid receptor transcription and nuclear translocation during single and repeated immobilization stress. Endocrinology. 2010;151(9):4344-4355.
39. Oitzl M.S., Champagne D.L., van der Veen R., de Kloet E.R. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci. Biobehav. Rev. 2010;34(6):853-866.
40. Pariante C.M. Depression, stress and the adrenal axis. J. Neuroendocrinol. 2003;15(8):811-812.
41. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiat. 2001;49(5):391-404.
42. Paskitti M.E., McCreary B.J., Herman J.P. Stress regulation of adrenocorticosteroid
43. receptor gene transcription and mRNA expression in rat hippocampus: time-course analysis. Brain. Res. Mol. Brain Res. 2000;80(2):142-152.
44. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiat. 1992;149(8):999-1010.
45. Putman P., Roelofs K. Effects of single cortisol administrations on human affect reviewed: Coping with stress through adaptive regulation of automatic cognitive processing. Psychoneuroendocrinology. 2011;36(4):439-448.
46. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985;117(6):2505-2511.
47. Reul J.M., Pearce P.T., Funder J.W., Krozowski Z.S. Type I and type II corticosteroid receptor gene expression in the rat: effect of adrenalectomy and dexamethasone administration. Mol. Endocrinol. 1989; 3(10):1674-1680.
48. Revest J.M., Le Roux A., Roullot-Lacarrière V., Kaouane N., Vallée M., Kasanetz F., Rougé-Pont F., Tronche F., Desmedt A., Piazza P.V. BDNF-TrkB signaling through Erk1/2 MAPK phosphorylation mediates the enhancement of fear memory induced by glucocorticoids. Mol. Psychiat. 2014;19(9):1001-1009.
49. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hörtnagl H., Flor H., Henn F.A., Schütz G., Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 2005;25(26):6243-6250.
50. Risch N., Herrell R., Lehner T., Liang K.Y., Eaves L., Hoh J., Griem A., Kovacs M., Ott J., Merikangas K.R. Interaction between the serotonin transporter gene (5- HTTLPR), stressful life events, and risk of depression: a meta-analysis. J. Amer. Med. Assoc. 2009;301(23): 2462-2471.
51. Robertson D.A., Beattie J.E., Reid I.C., Balfour D.J. Regulation of corticosteroid receptors in the rat brain: the role of serotonin and stress. Eur. J. Neurosci. 2005;21(6):1511-1520.
52. Sapolsky R.M., McEwen B.S. Down-regulation of neural corticosterone receptors by corticosterone and dexamethasone. Brain. Res. 1985;339(1):161-165.
53. Saveanu R.V., Nemeroff C.B. Etiology of depression: genetic and environmental factors. Psychiatr. Clin. North. Am. 2012;35(1):51-71.
54. Schulte-Herbrüggen O., Chourbaji S., Ridder S., Brandwein C., Gass P., Hörtnagl H., Hellweg R. Stress-resistant mice overexpressing glucocorticoid receptors display enhanced BDNF in the amygdala and hippocampus with unchanged NGF and serotonergic function. Psychoneuroendocrinology. 2006;31(10):1266-1277.
55. Shishkina G.T., Bulygina V.V., Dygalo N.N. Behavioral effects of glucocorticoids during the first exposures to the forced swim stress. Psychopharmacology (Berl.). 2015;232(5):851-860.
56. Skupio U., Tertil M., Sikora M., Golda S., Wawrzczak-Bargiela A., Przewlocki R. Behavioral and molecular alterations in mice resulting from chronic treatment with dexamethasone: relevance to depression. Neuroscience. 2015;286:141-150.
57. Snyder J.S., Soumier A., Brewer M., Pickel J., Cameron H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature. 2011;476(7361):458-461.
58. Sonino N., Fava G.A., Raffi A.R., Boscaro M., Fallo F. Clinical correlates of major depression in Cushing’s disease. Psychopathology. 1998;31(6):302-306.
59. Sterner E.Y., Kalynchuk L.E. Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression. Prog. Neuropsychopharmacol. Biol. Psychiat. 2010; 34(5):777-790.
60. Trujillo V., Durando P.E., Suárez M.M. Maternal separation in early life modifies anxious behavior and Fos and glucocorticoid receptor expression in limbic neurons after chronic stress in rats: effects of tianeptine. Stress. 2016;19(1):91-103.
61. van Praag H.M. Can stress cause depression? Prog. Neuropsychopharmacol. Biol. Psychiat. 2004;28(5):891-907.
62. Vincent M.Y., Hussain R.J., Zampi M.E., Sheeran K., Solomon M.B., Herman J.P., Khan A., Jacobson L. Sensitivity of depression-like behavior to glucocorticoids and antidepressants is independent of forebrain glucocorticoid receptors. Brain Res. 2013;1525:1-15.
63. Wang Q., Yu K., Wang J., Lin H., Wu Y., Wang W. Predator stressinduced persistent emotional arousal is associated with alterations of plasma corticosterone and hippocampal steroid receptors in rat. Behav. Brain Res. 2012;230(1):167-174.
64. Wei Q., Lu X.Y., Liu L., Schafer G., Shieh K.R., Burke S., Robinson T.E., Watson S.J., Seasholtz A.F., Akil H. Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc. Natl Acad. Sci. USA. 2004;101(32):11851-11856.
65. Xu Z., Hou B., Zhang Y., Gao Y., Wu Y., Zhao S., Zhang C. Antidepressive behaviors induced by enriched environment might be modulated by glucocorticoid levels. Eur. Neuropsychopharmacol. 2009; 19(12):868-875.
66. Zhao Y., Xie W., Dai J., Wang Z., Huang Y. The varying effects of shortterm and long-term corticosterone injections on depression-like behavior in mice. Brain. Res. 2009;1261:82-90.
67. Zhou J., Li L., Tang S., Cao X., Li Z., Li W., Li C., Zhang X. Effects of serotonin depletion on the hippocampal GR/MR and BDNF expression during the stress adaptation. Behav. Brain Res. 2008;195(1): 129-138.
Review
Views:
928
Email this article 